Q4 2025 13F Holders as of 31 Dec 2025
-
Type / Class
-
Equity / American Depositary Shares, each representing thirty-five (35) Ordinary Shares, no par value per share
-
Shares outstanding
-
843,913
-
Total 13F shares
-
842,827
-
Share change
-
+841,336
-
Total reported value
-
$12,161,983
-
Price per share
-
$14.43
-
Number of holders
-
18
-
Value change
-
+$12,140,475
-
Number of buys
-
18
Institutional Holders of Quoin Pharmaceuticals, Ltd. - American Depositary Shares, each representing thirty-five (35) Ordinary Shares, no par value per share (QNRX) as of Q4 2025
As of 31 Dec 2025,
Quoin Pharmaceuticals, Ltd. - American Depositary Shares, each representing thirty-five (35) Ordinary Shares, no par value per share (QNRX) was held by
18 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
842,827 shares.
The largest 10 holders included
Ikarian Capital, LLC, Woodline Partners LP, Stonepine Capital Management, LLC, Aberdeen Group plc, MILLENNIUM MANAGEMENT LLC, SummitTX Capital, L.P., BOOTHBAY FUND MANAGEMENT, LLC, ADAR1 Capital Management, LLC, AIGH Capital Management LLC, and Resolute Capital Asset Partners LLC.
This page lists
18
institutional shareholders reporting positions in this security
for the Q4 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.